Bharat Biotech's Covaxin Gets Approval for Phase 2/3 Trials on 2-18 Year-olds

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

from Top India News- News18.com https://ift.tt/3tFEN0j